Asthma Step-Down Strategies: Perhaps the Patient Should Decide?

Brian Lipworth (Lead / Corresponding author), Elliot Israel

Research output: Contribution to journalArticle

84 Downloads (Pure)
Original languageEnglish
Pages (from-to)644-645
Number of pages2
JournalThe Journal of Allergy and Clinical Immunology: In Practice
Volume6
Issue number2
Early online date7 Mar 2018
DOIs
Publication statusPublished - Mar 2018

Keywords

  • Asthma step down

Cite this

@article{f4cb01fa84fe4b6498a4d9c4a4833628,
title = "Asthma Step-Down Strategies: Perhaps the Patient Should Decide?",
keywords = "Asthma step down",
author = "Brian Lipworth and Elliot Israel",
note = "B. Lipworth has received research support from Teva, Meda, Boehringer Ingelheim, AstraZeneca, Chiesi, Sanofi, Janssen, and Roche; has received consultancy fees from Boehringer, Cipla, Dr Reddys, Sandoz, Chiesi, Teva, and Meda; has received travel support from Teva, Boehringer, Napp, and GlaxoSmithKline; and has a son who is employed by Boehringer Ingelheim. E. Israel has received consultancy fees from AstraZeneca, Philips Respironics, Regeneron Pharmaceuticals, Bird Rock Bio, Novelution Pharmaceuticals, Vitaeris, Sanofi, and Merck; has received consultancy fees from and is a member of the data and safety monitoring board for Novartis; has received travel support from Research in Real Life; has received consultancy fees and travel support from Teva Specialty Pharmaceuticals; and has received research support from Genentech, Boehringer Ingelheim, GlaxoSmithKline, Merck, Sunovion, Teva, and Sanofi.",
year = "2018",
month = "3",
doi = "10.1016/j.jaip.2017.08.026",
language = "English",
volume = "6",
pages = "644--645",
journal = "The Journal of Allergy and Clinical Immunology: In Practice",
issn = "2213-2198",
publisher = "Elsevier",
number = "2",

}

Asthma Step-Down Strategies : Perhaps the Patient Should Decide? / Lipworth, Brian (Lead / Corresponding author); Israel, Elliot .

In: The Journal of Allergy and Clinical Immunology: In Practice, Vol. 6, No. 2, 03.2018, p. 644-645.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Asthma Step-Down Strategies

T2 - Perhaps the Patient Should Decide?

AU - Lipworth, Brian

AU - Israel, Elliot

N1 - B. Lipworth has received research support from Teva, Meda, Boehringer Ingelheim, AstraZeneca, Chiesi, Sanofi, Janssen, and Roche; has received consultancy fees from Boehringer, Cipla, Dr Reddys, Sandoz, Chiesi, Teva, and Meda; has received travel support from Teva, Boehringer, Napp, and GlaxoSmithKline; and has a son who is employed by Boehringer Ingelheim. E. Israel has received consultancy fees from AstraZeneca, Philips Respironics, Regeneron Pharmaceuticals, Bird Rock Bio, Novelution Pharmaceuticals, Vitaeris, Sanofi, and Merck; has received consultancy fees from and is a member of the data and safety monitoring board for Novartis; has received travel support from Research in Real Life; has received consultancy fees and travel support from Teva Specialty Pharmaceuticals; and has received research support from Genentech, Boehringer Ingelheim, GlaxoSmithKline, Merck, Sunovion, Teva, and Sanofi.

PY - 2018/3

Y1 - 2018/3

KW - Asthma step down

U2 - 10.1016/j.jaip.2017.08.026

DO - 10.1016/j.jaip.2017.08.026

M3 - Article

C2 - 29524998

VL - 6

SP - 644

EP - 645

JO - The Journal of Allergy and Clinical Immunology: In Practice

JF - The Journal of Allergy and Clinical Immunology: In Practice

SN - 2213-2198

IS - 2

ER -